We are live on
!
Find out more
VRM
Vectors Research Management Portfolio holdings
AUM
$383M
1-Year Est. Return
30.23%
This Fund
S&P 500
This Quarter
Est. Return
+5.96%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$45M
(+22%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-53.72%
Top 10 Holdings %
Top 10 Hldgs %
44.54%
Holding
583
New
92
Increased
170
Reduced
50
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.14M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$3.05M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2.53M |
| 4 |
BlackRock Corporate High Yield Fund
HYT
|
+$2.41M |
| 5 |
Invesco Variable Rate Investment Grade ETF
VRIG
|
+$2.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$170M |
| 2 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$1.25M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$821K |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$477K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$417K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.23% |
| 2 | Technology | 9.88% |
| 3 | Financials | 6.34% |
| 4 | Healthcare | 3.61% |
| 5 | Real Estate | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVS Health
CVS
$115B
| $1.1M | 0.44% |
14,830
+5,075
| +52% | +$356K |
|
52
Cisco
CSCO
$435B
| $1.07M | 0.43% |
22,237
-240
| -1% | -$11.2K |
|
53
Chevron
CVX
$415B
| $1.02M | 0.41% |
8,467
+422
| +5% | +$49.7K |
|
54
Lockheed Martin
LMT
$124B
| $976K | 0.39% |
2,508
+783
| +45% | +$300K |
|
55
Texas Instruments
TXN
$236B
| $974K | 0.39% |
7,590
| – | – |
|
56
FMC
FMC
$1.28B
| $937K | 0.38% |
9,384
-83
| -0.9% | -$7.72K |
|
57
Bank of America
BAC
$407B
| $913K | 0.37% |
25,935
+20
| +0.1% | +$646 |
|
58
UnitedHealth
UNH
$337B
| $890K | 0.36% |
3,027
+136
| +5% | +$35.6K |
|
59
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $881K | 0.35% |
12,723
-337
| -3% | -$22.5K |
|
60
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$901M
| $880K | 0.35% |
+16,839
| New | +$879K |
|
61
ExxonMobil
XOM
$671B
| $875K | 0.35% |
12,540
+4,400
| +54% | +$304K |
|
62
Bristol-Myers Squibb
BMY
$128B
| $871K | 0.35% |
13,566
+450
| +3% | +$25.8K |
|
63
iShares Russell Mid-Cap ETF
IWR
$55.5B
| $799K | 0.32% |
13,400
| – | – |
|
64
Target
TGT
$72.6B
| $782K | 0.31% |
6,097
| – | – |
|
65
Intel
INTC
$575B
| $758K | 0.3% |
12,663
+410
| +3% | +$22.9K |
|
66
Ross Stores
ROST
$73.3B
| $699K | 0.28% |
6,000
| – | – |
|
67
RTX Corp
RTX
$261B
| $679K | 0.27% |
7,206
-1,128
| -14% | -$102K |
|
68
Altria Group
MO
$116B
| $672K | 0.27% |
13,473
+800
| +6% | +$37.7K |
|
69
Albemarle
ALB
$13.6B
| $662K | 0.27% |
9,063
+968
| +12% | +$64.6K |
|
70
American Express
AXP
$210B
| $654K | 0.26% |
5,250
| – | – |
|
71
Pfizer
PFE
$158B
| $609K | 0.25% |
16,389
-5,349
| -25% | -$191K |
|
72
Travelers Companies
TRV
$79.2B
| $590K | 0.24% |
4,309
+225
| +6% | +$30.6K |
|
73
General Dynamics
GD
$96.3B
| $543K | 0.22% |
3,078
| – | – |
|
74
Eli Lilly
LLY
$1.03T
| $523K | 0.21% |
3,980
| – | – |
|
75
Citigroup
C
$223B
| $522K | 0.21% |
6,540
+891
| +16% | +$65.8K |
|
Similar funds
RC
CA
PPWM
FAP
CC
PFU
HPM
SGCM
Vectors Research Management's Q4 2019 Portfolio in Review
As of Q4 2019, Vectors Research Management held 583 positions worth $249M, up 22% from $204M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Vectors Research Management withdrew a net $134M in Q4 2019, closing 33 positions and reducing 50 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $417K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 60% a quarter earlier, followed by Technology and Financials.
Against the trend, Vectors Research Management opened a new position in WisdomTree Yield Enhanced US Aggregate Bond Fund worth $880K.
- Vectors Research Management's largest Q4 2019 buy was WisdomTree Yield Enhanced US Aggregate Bond Fund: 16,839 shares worth $880K.
- Vectors Research Management added most to Vanguard S&P 500 ETF in Q4 2019, an estimated $3.14M increase.
- Vectors Research Management's biggest Q4 2019 reduction was Morgan Stanley, cutting an estimated $170M.
- Vectors Research Management fully exited Vanguard FTSE Emerging Markets ETF in Q4 2019, selling an estimated $417K.
- Vectors Research Management's ten largest holdings make up 45% of its $249M portfolio in Q4 2019.
- Vectors Research Management opened 92 new positions and closed 33 in Q4 2019.
- Vectors Research Management's portfolio value rose 22% quarter-over-quarter to $249M.
Based on Vectors Research Management's 13F filing for Q4 2019, filed 14 Feb 2020.